Code, Cells and the Golden State

"Fundamentally we're end users who are frustrated with the system and we're motivated enough to solve it"In this episode, Nick speaks to Rochana Wickramasinghe, Vice President, Head of Global Business Development of the AI-native operating system for global drug development Pi Health.Pi Health's mission is to make clinical research inclusive, efficient, and impactful - eliminating barriers, accelerating breakthrough therapies and ensuring diverse patient populations benefit from innovative medical advances. Their innovative platform FICS delivers breakthrough efficiencies, accelerates timelines, and ensures the highest data quality in clinical trials—empowering pharmaceutical companies and health systems to bring life-changing treatments to patients faster than ever before.

"We believe that the retina has the potential to become the non-invasive diagnosis platform of our times"In this episode, Nick speaks to Vasiliki (Vicky) Demas, founder, CEO and Board Director of innovative diagnostic platform Identifeye Health.Identifeye Health's mission is to leverage AI and automation to reimagine retinal imaging to prevent avoidable vision loss. With over $700 Million in funding, 300 scientists and engineers, they have created a non-invasive test that detects health conditions through the eyes, allowing for better diagnosis and treatment.

"We're not competing with other Genomics companies - we're competing with Mr Beast"In this episode, Nick welcomes Kian Sadeghi, founder and CEO of disruptive consumer health platform Nucleus Genomics.Nucleus Genomics technology provides consumers with an easily accessible all-in-one DNA health test, and is redefining how we leverage our DNA data. Kian's vision is that each and every person will have full control of their genetic data, allowing for personal healthcare strategies we didn't think were possible.

"The fact that we have not solved disease, is unacceptable" In the premier episode, Nick welcomes Mohit Jain, founder and Chief Scientific Officer of multi-omics data analysis service provider Sapient. Sapient's multi-omnic data analysis help identify and validate the biologically relevant biomarkers, allowing for the accelerated diagnosis of disease, prediction of health outcomes and more effective treatment of people worldwide.